While Shivappa et al. [44] previously validated the DII tool as a method to predict circulating CRP concentrations, to-date, blood analysis has not been included in a study exploring the association between DII and sarcopenia symptomology, highlighting an area of focus for future research. This evidence concerns the gene CRP and sarcopenia.